- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
SteelPeak Wealth LLC Acquires New Bristol Myers Squibb Shares
The investment firm added over 36,000 shares of the biopharmaceutical company in Q4 2025.
Apr. 5, 2026 at 9:24am
Got story updates? Submit your updates here. ›
SteelPeak Wealth LLC acquired a new position in Bristol Myers Squibb Company (NYSE:BMY) in the fourth quarter, according to the firm's most recent 13F filing with the SEC. The fund purchased 36,357 shares of the biopharmaceutical company's stock, valued at approximately $1.96 million.
Why it matters
This purchase by SteelPeak Wealth reflects ongoing investor interest in Bristol Myers Squibb, a major player in the pharmaceutical industry. The company's diverse drug portfolio and pipeline have made it an attractive investment target, despite some recent earnings misses.
The details
According to the 13F filing, SteelPeak Wealth LLC added the 36,357 shares of Bristol Myers Squibb to its portfolio in the fourth quarter. The shares were valued at approximately $1.96 million. This represents a new position for the investment firm in the biopharmaceutical company.
- SteelPeak Wealth LLC acquired the new Bristol Myers Squibb shares in the fourth quarter of 2025.
- The 13F filing disclosing this transaction was published on April 5, 2026.
The players
SteelPeak Wealth LLC
An investment management firm that acquired a new position in Bristol Myers Squibb Company in the fourth quarter of 2025.
Bristol Myers Squibb Company
A global biopharmaceutical company focused on discovering, developing, and delivering medicines for serious diseases.
The takeaway
This purchase by SteelPeak Wealth demonstrates ongoing investor interest in Bristol Myers Squibb, a major pharmaceutical company with a diverse drug portfolio. While the company has faced some recent earnings challenges, its pipeline and market position continue to make it an attractive investment target.
